Lim S - Search Results

1

Jang AY, Lim S, Jo SH, Han SH, Koh KK. Jang AY, et al. Among authors: lim s. Circ J. 2021 May 25;85(6):759-768. doi: 10.1253/circj.CJ-20-1037. Epub 2020 Nov 12. Circ J. 2021. PMID: 33177309 Free article. Review.

2

Effects of fenofibrate therapy on circulating adipocytokines in patients with primary hypertriglyceridemia.

Koh KK, Quon MJ, Lim S, Lee Y, Sakuma I, Lee YH, Han SH, Shin EK. Koh KK, et al. Among authors: lim s. Atherosclerosis. 2011 Jan;214(1):144-7. doi: 10.1016/j.atherosclerosis.2010.10.023. Epub 2010 Oct 29. Atherosclerosis. 2011. PMID: 21075373 Clinical Trial.

3

Effects of simvastatin therapy on circulating adipocytokines in patients with hypercholesterolemia.

Koh KK, Quon MJ, Sakuma I, Lee Y, Lim S, Han SH, Shin EK. Koh KK, et al. Among authors: lim s. Int J Cardiol. 2011 Feb 3;146(3):434-7. doi: 10.1016/j.ijcard.2010.10.103. Epub 2010 Nov 20. Int J Cardiol. 2011. PMID: 21095021 Clinical Trial. No abstract available.

4

Prevention of atherosclerosis in overweight/obese patients. - In need of novel multi-targeted approaches-.

Lim S, Despres JP, Koh KK. Lim S, et al. Circ J. 2011;75(5):1019-27. doi: 10.1253/circj.cj-10-1240. Epub 2011 Mar 25. Circ J. 2011. PMID: 21441697 Free article. Review.

5

Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007.

Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, Choi SH, Cho SI, Park KS, Lee HK, Jang HC, Koh KK. Lim S, et al. Diabetes Care. 2011 Jun;34(6):1323-8. doi: 10.2337/dc10-2109. Epub 2011 Apr 19. Diabetes Care. 2011. PMID: 21505206 Free PMC article.

6

Caveats to aggressive lowering of lipids by specific statins.

Koh KK, Lim S, Sakuma I, Quon MJ. Koh KK, et al. Among authors: lim s. Int J Cardiol. 2012 Jan 26;154(2):97-101. doi: 10.1016/j.ijcard.2011.09.002. Epub 2011 Oct 11. Int J Cardiol. 2012. PMID: 21993228 No abstract available.

7

Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia.

Koh KK, Quon MJ, Shin KC, Lim S, Lee Y, Sakuma I, Lee K, Han SH, Shin EK. Koh KK, et al. Among authors: lim s. Atherosclerosis. 2012 Feb;220(2):537-44. doi: 10.1016/j.atherosclerosis.2011.11.018. Epub 2011 Nov 19. Atherosclerosis. 2012. PMID: 22153696 Clinical Trial.

8

How to control residual cardiovascular risk despite statin treatment: focusing on HDL-cholesterol.

Lim S, Park YM, Sakuma I, Koh KK. Lim S, et al. Int J Cardiol. 2013 Jun 5;166(1):8-14. doi: 10.1016/j.ijcard.2012.03.127. Epub 2012 Apr 12. Int J Cardiol. 2013. PMID: 22503572 Review.

9

Potentially important considerations in choosing specific statin treatments to reduce overall morbidity and mortality.

Lim S, Sakuma I, Quon MJ, Koh KK. Lim S, et al. Int J Cardiol. 2013 Sep 1;167(5):1696-702. doi: 10.1016/j.ijcard.2012.10.037. Epub 2012 Nov 16. Int J Cardiol. 2013. PMID: 23159411 Review.

10

Comparative cardiometabolic effects of fibrates and omega-3 fatty acids.

Han SH, Oh PC, Lim S, Eckel RH, Koh KK. Han SH, et al. Among authors: lim s. Int J Cardiol. 2013 Sep 10;167(6):2404-11. doi: 10.1016/j.ijcard.2013.01.223. Epub 2013 Feb 27. Int J Cardiol. 2013. PMID: 23452884 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,572 results

Search Page